ClinicalTrials.Veeva

Menu

Empathy in Action: Sunshine Calls for Life With Diabetes (EIA-Diabetes)

The University of Texas System (UT) logo

The University of Texas System (UT)

Status

Completed

Conditions

Diabetes
Health Behavior
Diabetes Mellitus, Type 2
Mental Health

Treatments

Behavioral: Control Phase 2 Materials Only
Behavioral: Empathy in Action for life with diabetes.

Study type

Interventional

Funder types

Other

Identifiers

NCT05173675
STUDY00001571

Details and patient eligibility

About

Randomized controlled trial of the effectiveness in managing diabetes and improving mental health through a telephonic layperson-delivered empathy and relationship-focused program for patients at a Federally Qualified Health Center (FQHC) against usual care.

Full description

In this study, we will assess the effectiveness of a 6-month program delivered by phone by lightly-trained lay people to individuals with diabetes, with the goal of empathetic relationship building and engagement to support day-to-day challenges of managing diabetes and working towards self-management goals. We will recruit from a collaborating Federally Qualified Health Center (FQHC) and use a randomized controlled trial, comparing program to usual care. Telephone callers will be lay people (no formal health training) who will be recruited for authentic interest and empathetic skills and lightly trained on conversational skills, cultural nuances, and how best to support people's individual lifestyle goals on nutrition, exercise, sleep and medication adherence. Callers will encourage participants to seek additional help from their clinic or specific social services as needs arise that benefit from early escalation.

Enrollment

260 patients

Sex

All

Ages

21 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • HbA1c ≥ 7.5% at baseline measurement and 8.0% at least one time 12 months prior to study enrollment.
  • At least one visit with Lone Star Circle of Care within the past 12 months (in person or telehealth)
  • Willing to answer the PHQ-9 form in its entirety at baseline data collection (due to stratified randomization design).

Exclusion criteria

  • HbA1c < 7.5% at baseline measurement.
  • Refusal to answer the PHQ-9 form in its entirety at baseline data collection.
  • Moderate to severe cognitive impairment
  • Currently pregnant (if of female sex)
  • Undergoing cancer treatment
  • Having diagnosis of end-stage renal disease or serious mental illness
  • Having moderate to severe cognitive impairment
  • Receiving systemic treatment with prednisone or immunosuppressant therapy following an organ transplant

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

260 participants in 2 patient groups

Program arm
Experimental group
Description:
Usual Care+ Phase 1 (6 months, months 1-6), Program. Includes empathetic communications (phone \& letter), health-promoting incentives, educational materials. Phase 2 (6 months, months 7-12) No Program. During this follow-up period they will receive monthly SMS texts with customized messages encouraging health promoting behaviors.
Treatment:
Behavioral: Empathy in Action for life with diabetes.
Control arm
Other group
Description:
Usual Care+ Phase 1 (6 months, months 1-6), No Program. Phase 2 (6 months, months 7-12) Material components of program including health-promoting incentives and educational materials.
Treatment:
Behavioral: Control Phase 2 Materials Only

Trial documents
2

Trial contacts and locations

9

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems